Basic information |
Metabolite name | Propionic acid |
HMDB0000237 | |
C00163 | |
1032 | |
Synonyms | Propionic acid; |
No. of studies | 45 |
Relationship between Propionic acid and depression (count: 45) |
Study | Study Type | Comparison groups | Tissue | Organism | Up/Down regulated |
Study M088 | Type3 | venlafaxine group vs. control group | Faece | Wistar rat | Down |
Study M1001 | Type3 | Roseburia hominis group vs. control group | Serum | Sprague-Dawley rat | Up |
Study M1002 | Type2 | high-fat diet + Xiaoyao San group vs. high-fat diet group | Faece | C57Bl6/J mouse | Up |
Study M1002 | Type2 | high-fat diet + Faecalibaculum rodentium group vs. high-fat diet group | Faece | C57Bl6/J mouse | Up |
Study M1006 | Type2 | maternal separation + Bifidobacterium breve CCFM1025 group vs. maternal separation group | Faece | C57BL/6J mouse | Up |
Study M1009 | Type1 | CUMS group vs. control group | Faece | C57BL/6 mouse | Down |
Study M1009 | Type2 | CUMS + multi-probiotics group vs. CUMS group | Faece | C57BL/6 mouse | Up |
Study M1016 | Type1 | CUMS group vs. control group | Faece | C57BL/6J mouse | Down |
Study M1016 | Type2 | CUMS + imipramine group vs. CUMS group | Faece | C57BL/6J mouse | Up |
Study M1016 | Type2 | CUMS + ginsenoside Rh4 group vs. CUMS group | Faece | C57BL/6J mouse | Up |
Study M1019 | Type1 | depression group vs. control group | Serum | Human | Up |
Study M1026 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Down |
Study M1027 | Type1 | CUMS group vs. control group | Faece | Wistar rat | Up |
Study M1027 | Type2 | CUMS + high dose of berberine group vs. CUMS group | Faece | Wistar rat | Down |
Study M1027 | Type2 | CUMS + low dose of berberine group vs. CUMS group | Faece | Wistar rat | Down |
Study M1027 | Type2 | CUMS + fluoxetine group vs. CUMS group | Faece | Wistar rat | Down |
Study M1048 | Type2 | adult high-fat diet + probiotic group vs. adult high-fat diet group | Faece | CD-1 mouse | Up |
Study M1048 | Type3 | adult probiotic group vs. adult control group | Faece | CD-1 mouse | Up |
Study M1086 | Type1 | CUMS group vs. control group | Faece | C57BL/6 mouse | Down |
Study M1087 | Type1 | CSDS group vs. control group | Faece | C57BL/6 mouse | Down |
Study M1097 | Type1 | placebo-treated depression group vs. control group | Faece | Human | Down |
Study M1127 | Type2 | flavonoid-rich orange juice group, after 8-week treatment vs. baseline | Faece | Human | Up |
Study M487 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
Study M522 | Type1 | CUMS group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Unknown |
Study M536 | Type1 | naturally-occurring depression group vs. control group | Cerebrospinal fluid | Cynomolgus monkey | Up |
Study M547 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
Study M610 | Type1 | CUMS group vs. control group | Heart | Sprague-Dawley rat | Down |
Study M611 | Type1 | LPS group vs. control group | Heart | Sprague-Dawley rat | Unknown |
Study M615 | Type1 | high-fat diet group vs. control group | Faece | C57BL/6J mouse | Down |
Study M636 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Up |
Study M636 | Type2 | CUMS + Xiaoyaosan group vs. CUMS group | Faece | Sprague-Dawley rat | Down |
Study M636 | Type2 | CUMS + Shugan group vs. CUMS group | Faece | Sprague-Dawley rat | Down |
Study M665 | Type1 | CRS group vs. control group | Faece | C57BL/6 mouse | Down |
Study M667 | Type2 | CRS + crocin-I group vs. CRS group | Faece | C57BL/6 J mouse | Up |
Study M678 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Down |
Study M706 | Type1 | CUMS group vs. control group | Faece | C57BL/6 mouse | Down |
Study M706 | Type2 | CUMS + CCFM1025 group vs. CUMS group | Faece | C57BL/6 mouse | Up |
Study M707 | Type2 | CUMS + F45BB group vs. CUMS group | Faece | C57BL/6J mouse | Up |
Study M707 | Type2 | CUMS + S60 group vs. CUMS group | Faece | C57BL/6J mouse | Up |
Study M708 | Type2 | CUMS + fluoxetine group vs. CUMS group | Faece | C57BL/6J mouse | Up |
Study M732 | Type1 | CUMS + high dose of propionate group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Unknown |
Study M778 | Type1 | LPS group vs. control group | Faece | C57BL/6J mouse | Down |
Study M778 | Type2 | LPS + NU9056 group vs. LPS group | Faece | C57BL/6J mouse | Up |
Study M804 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Down |
Study M804 | Type2 | CUMS + high dose of WYJYD group vs. CUMS group | Faece | Sprague-Dawley rat | Up |
Study M804 | Type2 | CUMS + fluoxetine group vs. CUMS group | Faece | Sprague-Dawley rat | Up |
Study M804 | Type2 | CUMS + middle dose of WYJYD group vs. CUMS group | Faece | Sprague-Dawley rat | Up |
Study M821 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Up |
Study M835 | Type1 | CRS group vs. control group | Faece | C57BL/6 mouse | Down |
Study M872 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
Study M872 | Type1 | CUMS group vs. control group | Brain | Sprague-Dawley rat | Down |
Study M872 | Type2 | CUMS + rifaximin group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
Study M886 | Type1 | lead-exposed group vs. control group | Faece | Sprague-Dawley rat | Down |
Study M886 | Type2 | lead-exposed + probiotics group vs. lead-exposed group | Faece | Sprague-Dawley rat | Up |
Study M900 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Up |
Study M900 | Type2 | CUMS + Semen Sojae Praeparatum group vs. CUMS group | Faece | Sprague-Dawley rat | Down |
Study M901 | Type1 | LPS group vs. control group | Faece | C57BL/6 mouse | Down |
Study M901 | Type2 | LPS + Schisandrin group vs. LPS group | Faece | C57BL/6 mouse | Up |
Study M934 | Type1 | CUS + high-fat diet group vs. control group | Serum | C57BL/6J mouse | Down |
Study M934 | Type2 | CUS + high-fat diet + 5-hydroxytryptophan group vs. CUS + high-fat diet group | Serum | C57BL/6J mouse | Up |
Study M943 | Type2 | CUMS + low dose of Acanthopanax senticosus Harms group vs. CUMS group | Liver | ICR mouse | Down |
Study M965 | Type1 | CUMS depression group vs. control group | Faece | Sprague-Dawley rat | Up |
Study M967 | Type1 | bilateral common carotid artery occlusion group vs. control group | Serum | Sprague-Dawley rat | Down |
Study M971 | Type2 | CUMS + Tao-Hong-Si-Wu decoction group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
Study M981 | Type1 | Abeta oligomer group vs. control group | Serum | ICR mouse | Down |
Study M981 | Type2 | Abeta oligomer + involuntary and voluntary running + acousto-optic stimulation group vs. Abeta oligomer group | Serum | ICR mouse | Up |
Study M985 | Type2 | CUMS + indole acetic acid group vs. CUMS group | Cecum | C57BL/6J mouse | Up |
Study M990 | Type1 | aged microbiota transplant group vs. young microbiota transplant group | Faece | C57BL/6 mouse | Down |